Skip to main content
TipRanks
Go Ultimate75% OFF

PharmX Technologies (PHX) Share Price & Analysis

2 Followers

PHX Stock Chart & Stats

A$0.07A$0.00(0.00%)
At close: 4:00 PM GMT+11
AU$0.07AU$0.08AU$0.09AU$0.1Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
AUD 0.07 - AUD 0.07
52-Week Range
AUD 0.06 - AUD 0.18
Previous Close
AUD 0.07
Volume
N/A
Average Volume (3M)
857.89K
Market Cap
AUD 46.13M
Enterprise Value
AUD 79.67M
Total Cash (Recent Filing)
AUD 2.57M
Total Debt (Recent Filing)
AUD 540.00K
Price to Earnings (P/E)
―
Beta
0.65
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Conservative Leverage

Debt-to-equity of about 0.02 in 2026 versus 0.06 in 2025 indicates limited leverage, while equity rose to about 23.3M. This gives PHX more capacity to absorb operating setbacks and fund initiatives without substantial debt-service pressure.

Expanded Capital Base

Assets expanded from about 18.8M to 27.3M year over year, alongside higher equity. A larger capital base can support ongoing operations and provide financial flexibility over the next several quarters, although its value depends on restoring profitability.

Positive 2026 Cash Generation

Positive 2026 operating cash flow of about 0.83M and free cash flow of about 0.81M show that PHX generated cash despite reported losses. If maintained, this could reduce dependence on external funding and support resilience, though the historical swing makes durability unproven.

Bears Say

Revenue Contraction

Revenue fell about 19.2% year over year in 2026, signaling a materially weaker top-line outcome. Sustained contraction would reduce operating leverage, constrain investment capacity, and make it harder for PHX to recover margins and reach profitability.

Negative Gross Margin

Gross margin turned slightly negative at about -0.9% in 2026, versus strong gross profit in 2025, while operating performance weakened sharply. This reversal indicates the reported revenue base was not covering direct costs, obstructing sustainable earnings.

Volatile Cash Flow

Cash generation swung from approximately 8.1M of operating and free cash outflow in 2025 to positive results in 2026, while 2026 free cash flow still declined 17.7% year over year. This volatility weakens confidence in durable self-funding.

PharmX Technologies News

PHX FAQ

What was PharmX Technologies’s price range in the past 12 months?
PharmX Technologies lowest share price was AU$0.06 and its highest was AU$0.18 in the past 12 months.
What is PharmX Technologies’s market cap?
PharmX Technologies’s market cap is AU$46.13M.
When is PharmX Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PharmX Technologies’s earnings last quarter?
PharmX Technologies released its earnings results on Aug 26, 2026. The company reported -AU$0.002 earnings per share for the quarter.
Is PharmX Technologies overvalued?
According to Wall Street analysts PharmX Technologies’s price is currently Undervalued.
Does PharmX Technologies pay dividends?
PharmX Technologies pays a dividend of AU$0.008 which represents an annual dividend yield of ―. See more information on PharmX Technologies dividends here
What is PharmX Technologies’s EPS estimate?
PharmX Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PharmX Technologies have?
PharmX Technologies has 668,618,650 shares outstanding.
What happened to PharmX Technologies’s price movement after its last earnings report?
PharmX Technologies reported an EPS of -AU$0.002 in its last earnings report. Following the earnings report the stock price went down -4.762%.
Which hedge fund is a major shareholder of PharmX Technologies?
Currently, no hedge funds are holding shares in AU:PHX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology